Pharmaceutical Business review

CEM Establishes New Japanese Subsidiary

Reportedly, CEM Japan will take care of all sales, marketing, technical support and service of the company’s entire line of laboratory instrumentation in Japan and selected areas of Asia. The offices are expected to initiate operation in the fall of 2010.

The new subsidiary is expected to strengthen all of the major market areas for each of CEM’s business units: Analytical, Process Control, Chemical Synthesis and Bioscience. Initial areas of focus will include the analytical laboratory and peptide synthesis markets.

CEM said that its new analytical laboratory system, Discover SP-D, is expected to have broad applications in Japan.

CEM said that the Japan subsidiary would employ approximately 10 people in 2010 and gradually add more employees over the next three years, as the considerable expansion of business in the region and its R&D pipeline is expected to create substantial future growth.